Related Experiment Video
Updated: May 16, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Pharmacokinetics of nebulized terbinafine in Hispaniolan Amazon parrots (Amazona ventralis)
Lee C Emery1, Sherry K Cox, Marcy J Souza
1Class of 2013, University of Tennessee College of Veterinary Medicine, 2407 River Dr, Knoxville, TN 37996, USA.
Abstract:
Aspergillosis is one of the most difficult diseases to treat successfully in avian species. Terbinafine hydrochloride offers numerous potential benefits over traditionally used antifungals for treatment of this disease. Adding nebulized antifungals to treatment strategies is thought to improve clinical outcomes in lung diseases. To determine plasma concentrations of terbinafine after nebulization, 6 adult Hispaniolan Amazon parrots were randomly divided into 2 groups of 3. Each bird was nebulized for 15 minutes with 1 of 2 terbinafine solutions, one made with a crushed tablet and the second with raw drug powder. Blood samples were collected at baseline and at multiple time points up to 720 minutes after completing nebulization. Plasma and nebulization solutions were analyzed by high-performance liquid chromatography. The terbinafine concentration of the solution made with a crushed tablet (0.87 +/- 0.05 mg/mL) was significantly lower than was that made with raw powder (1.02 +/- 0.09 mg/mL). Plasma concentrations of terbinafine did not differ significantly between birds in the 2 groups. Plasma terbinafine concentrations in birds were maintained above in vitro minimum inhibitory concentrations for approximately 1 hour in birds nebulized with the crushed tablet solution and 4 hours in birds nebulized with the raw powder solution. Higher concentrations of solution, longer nebulization periods, or more frequent administration are likely needed to reach therapeutic plasma concentrations of terbinafine for clinically relevant periods in Hispaniolan Amazon parrots.
Insights
Nebulized terbinafine hydrochloride for avian aspergillosis showed short-lived plasma concentrations. Raw drug powder yielded longer therapeutic levels than crushed tablets, suggesting optimized delivery is needed for effective treatment.
Area of Science:
- Veterinary Medicine
- Pharmacology
- Avian Health
Background:
- Aspergillosis is a challenging avian fungal disease.
- Terbinafine hydrochloride presents potential advantages over traditional antifungals.
- Nebulization may enhance antifungal treatment efficacy in avian lung diseases.
Purpose of the Study:
- To determine plasma concentrations of terbinafine after nebulization in Hispaniolan Amazon parrots.
- To compare plasma terbinafine levels from two different nebulization solutions (crushed tablet vs. raw powder).
Main Methods:
- Six Hispaniolan Amazon parrots were divided into two groups.
- Birds were nebulized for 15 minutes with either a crushed tablet or raw powder terbinafine solution.
- Plasma samples were collected up to 720 minutes post-nebulization and analyzed using high-performance liquid chromatography.
Main Results:
- The raw powder solution had a significantly higher terbinafine concentration than the crushed tablet solution.
- No significant difference in plasma terbinafine concentrations was observed between the two groups.
- Plasma terbinafine remained above in vitro minimum inhibitory concentrations for approximately 1 hour (crushed tablet) and 4 hours (raw powder).
Conclusions:
- Nebulized terbinafine achieved transient plasma concentrations in parrots.
- The raw powder formulation provided a longer duration above minimum inhibitory concentrations compared to the crushed tablet.
- Higher concentrations, longer nebulization, or more frequent administration may be necessary for therapeutic efficacy in avian aspergillosis.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
06:49Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Antifungal Agents
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Pharmacokinetics: Overview